Gayam, Vijay <br/><br/>
Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African-American patients: a community-based retrospective cohort study.  [electronic resource] 

 -  European journal of gastroenterology & hepatology  10 2018 
 - 1200-1207 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1473-5687 
<br/><br/><label>Standard No.: </label>10.1097/MEG.0000000000001233  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Black or African American<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--adverse effects<br/>Benzimidazoles--adverse effects<br/>Carbamates--adverse effects<br/>Community Health Centers<br/>Drug Therapy, Combination--adverse effects<br/>Female<br/>Fluorenes--adverse effects<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Heterocyclic Compounds, 4 or More Rings--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Ribavirin--therapeutic use<br/>Simeprevir--adverse effects<br/>Sofosbuvir--adverse effects<br/>Sustained Virologic Response